nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases
|
Schett, Georg |
|
2010 |
|
5 |
p. 271-278 |
artikel |
2 |
Atherosclerosis in psoriatic disease: latest evidence and clinical implications
|
Eder, Lihi |
|
2015 |
|
5 |
p. 187-195 |
artikel |
3 |
Best performing definition of accelerated knee osteoarthritis: data from the Osteoarthritis Initiative
|
Driban, Jeffrey B. |
|
2016 |
|
5 |
p. 165-171 |
artikel |
4 |
Bone disease in primary hyperparathyrodism
|
Marcocci, Claudio |
|
2012 |
|
5 |
p. 357-368 |
artikel |
5 |
Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach
|
Hodkinson, Bridget |
|
2016 |
|
5 |
p. 172-179 |
artikel |
6 |
Combination therapy with biologic agents in rheumatic diseases: current and future prospects
|
Inui, Kentaro |
|
2016 |
|
5 |
p. 192-202 |
artikel |
7 |
Controversies and challenges in fibromyalgia: a review and a proposal
|
Cohen, Helen |
|
2017 |
|
5 |
p. 115-127 |
artikel |
8 |
DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug
|
Bello, Alfonso E. |
|
2012 |
|
5 |
p. 327-339 |
artikel |
9 |
Experience with subcutaneous abatacept for rheumatoid arthritis: an update for clinicians
|
Khraishi, Majed M. |
|
2014 |
|
5 |
p. 159-168 |
artikel |
10 |
Making the next steps in psoriatic arthritis management: current status and future directions
|
Sritheran, Diviya |
|
2015 |
|
5 |
p. 173-186 |
artikel |
11 |
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations
|
Tournadre, Anne |
|
2016 |
|
5 |
p. 180-191 |
artikel |
12 |
Managing hip and knee osteoarthritis with exercise: what is the best prescription?
|
Iversen, Maura Daly |
|
2010 |
|
5 |
p. 279-290 |
artikel |
13 |
Medication-induced osteoporosis: screening and treatment strategies
|
Panday, Keshav |
|
2014 |
|
5 |
p. 185-202 |
artikel |
14 |
Novel approaches in the treatment of myositis and myopathies
|
Albayda, Jemima |
|
2012 |
|
5 |
p. 369-377 |
artikel |
15 |
Opioids in chronic musculoskeletal conditions
|
Calvo-Alén, Jaime |
|
2010 |
|
5 |
p. 291-297 |
artikel |
16 |
Role of diagnostic ultrasound in the assessment of musculoskeletal diseases
|
Patil, Pravin |
|
2012 |
|
5 |
p. 341-355 |
artikel |
17 |
Sarcoidosis: a rheumatologist’s perspective
|
Kobak, Senol |
|
2015 |
|
5 |
p. 196-205 |
artikel |
18 |
Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes
|
Smith, Jessica W. |
|
2012 |
|
5 |
p. 315-325 |
artikel |
19 |
Strontium ranelate in the treatment of knee osteoarthritis: new insights and emerging clinical evidence
|
Reginster, Jean-Yves |
|
2013 |
|
5 |
p. 268-276 |
artikel |
20 |
The calcium and vitamin D controversy
|
Abrahamsen, Bo |
|
2017 |
|
5 |
p. 107-114 |
artikel |
21 |
The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology
|
Kotyla, Przemyslaw |
|
2010 |
|
5 |
p. 257-269 |
artikel |
22 |
The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis
|
Srirangan, Srinivasan |
|
2010 |
|
5 |
p. 247-256 |
artikel |
23 |
Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implications
|
Cribbs, Adam |
|
2015 |
|
5 |
p. 206-219 |
artikel |
24 |
Treatment of osteoporosis in men with bisphosphonates: rationale and latest evidence
|
Sim, Ie-Wen |
|
2013 |
|
5 |
p. 259-267 |
artikel |
25 |
Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know
|
Krause, Megan L. |
|
2014 |
|
5 |
p. 169-184 |
artikel |
26 |
Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
|
Gottlieb, Alice |
|
2013 |
|
5 |
p. 277-285 |
artikel |